本文選題：周圍動(dòng)脈疾病 + 下肢動(dòng)脈疾病　； 參考：《重慶醫(yī)科大學(xué)》2017年碩士論文

【摘要】：背景:周圍動(dòng)脈疾病(PAD)是一種嚴(yán)重危害身體健康,高致殘率、高死亡率的疾病,隨著人口老齡化和飲食結(jié)構(gòu)的變化,PAD已成為全球性的問題。除了改變生活方式、嚴(yán)格戒煙及應(yīng)用藥物等保守治療外,手術(shù)治療是重要的治療手段。相關(guān)技術(shù)的不斷進(jìn)步,腔內(nèi)治療PAD的應(yīng)用和適應(yīng)癥越來越廣泛,并且與傳統(tǒng)外科治療方式相比,腔內(nèi)治療有著低創(chuàng)傷、較高的可重復(fù)性等優(yōu)勢(shì)。然而支架內(nèi)再狹窄(in-stent restenosis,ISR)等問題也日益突出,越來越引起人們的重視。DCB、DES等新興技術(shù)的出現(xiàn)旨在以腔內(nèi)治療方式解決ISR,減少再次手術(shù)的創(chuàng)傷。目的:通過綜述目前腔內(nèi)治療PAD及ISR等方面的研究,從而為臨床上更好的治療PAD提供一些參考。方法:以“周圍動(dòng)脈疾病、下肢動(dòng)脈疾病、股乆動(dòng)脈疾病、腔內(nèi)治療、藥物洗脫支架、藥物涂層球囊、支架內(nèi)再狹窄”等關(guān)鍵詞進(jìn)行檢索,找出腔內(nèi)治療PAD及ISR的相關(guān)研究。結(jié)果與結(jié)論:目前有大量有關(guān)PAD腔內(nèi)治療的文獻(xiàn),綜合這些研究結(jié)果表明腔內(nèi)治療是目前治療PAD可以首先被考慮的方式;傳統(tǒng)腔內(nèi)治療有著較高的ISR;DCB和DES的研究旨在以腔內(nèi)治療的方式解決ISR,其治療效果較傳統(tǒng)腔內(nèi)治療明顯提升,但仍有許多問題亟待解決。
[Abstract]:Background: peripheral artery disease (PAD) is a serious health hazard, high disability rate, high mortality disease. With the aging of population and changes in dietary structure, pad has become a global problem. In addition to lifestyle changes, strict smoking cessation and conservative treatment such as drug use, surgical treatment is an important treatment. With the development of related technology, endovascular treatment of PAD is more and more widely used and indications. Compared with the traditional surgical treatment, endovascular treatment has the advantages of low trauma and high reproducibility. However, the problems of restenosissis-in-stent (ISR) are becoming more and more prominent, and the emergence of new technologies, such as .DCBPDES, is aimed at solving ISRs by endovascular treatment and reducing the trauma caused by reoperation. Objective: to provide some references for better clinical treatment of PAD by reviewing the current studies on endovascular treatment of PAD and ISR. Methods: "peripheral artery disease, lower extremity arterial disease, femoral artery disease, intravascular therapy, drug-eluting stents, drug-coated balloon, restenosis in stents" were used to find out the related studies of intracavitary treatment of PAD and ISR. Results & conclusion: there are a lot of literatures about intracavitary treatment of PAD. These results indicate that endovascular therapy is the first method to be considered in the treatment of PAD. The traditional intracavitary therapy has higher ISR DCB and DES. The purpose of this study is to solve the problem by endovascular therapy. The therapeutic effect of traditional endovascular therapy is much better than that of traditional intracavitary therapy, but there are still many problems to be solved.
【學(xué)位授予單位】：重慶醫(yī)科大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2017
【分類號(hào)】：R543.5

【參考文獻(xiàn)】

相關(guān)期刊論文 前4條

1 ;下肢動(dòng)脈硬化閉塞癥診治指南[J];中華醫(yī)學(xué)雜志;2015年24期

2 張文俐;杜潤(rùn);朱政斌;朱勁舟;應(yīng)晨;劉慧竹;張瑞巖;;藥物洗脫球囊抑制下肢動(dòng)脈狹窄性病變的實(shí)驗(yàn)研究[J];介入放射學(xué)雜志;2014年05期

3 王洪劍;鄧鋼;秦永林;李國(guó)昭;柏志斌;何仕誠(chéng);郭金和;丁惠娟;沈志萍;;球囊擴(kuò)張或(和)支架植入術(shù)治療股淺動(dòng)脈狹窄或閉塞的中遠(yuǎn)期療效[J];介入放射學(xué)雜志;2012年10期

4 包俊敏;;下肢動(dòng)脈閉塞性疾病腔內(nèi)治療進(jìn)展[J];中國(guó)普外基礎(chǔ)與臨床雜志;2010年07期

，

本文編號(hào)：1958721